Gewinn- und Verlustrechnung von CVS Health Corp.

It has added considerably to the company's fundamentals. Zooming out, CVS has crushed analyst profitability estimates lately.

Allworth Financial LP bought a new stake in CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 33,215 shares of the pharmacy operator's stock, valued at approximately $3,436,000. Other institutional investors have also modified their

Mark Cuban says AI will never replace radiologists, and his reasoning has nothing to do with capability. The real disruption, he argues, targets a different layer of medicine entirely, one worth hundreds of billions in enterprise value at some of the biggest names in healthcare.

B. Metzler seel. Sohn and Co. AG acquired a new stake in CVS Health Corporation (NYSE: CVS) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 123,784 shares of the pharmacy operator's stock, valued at approximately $12,805,000. A number

Bank of New York Mellon Corp purchased a new stake in CVS Health Corporation (NYSE: CVS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,013,571 shares of the pharmacy operator's stock, valued at approximately $932,454,000.

Asahi Life Asset Management CO. LTD. purchased a new position in shares of CVS Health Corporation (NYSE: CVS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,630 shares of the pharmacy operator's stock, valued at approximately $582,000. Other institutional investors and hedge

AssuredPartners Investment Advisors LLC bought a new stake in CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,401 shares of the pharmacy operator's stock, valued at approximately $559,000. Several other large investors have also recently added

Novo Nordisk, CVS Health, and Bristol Myers are top dividend stocks that are trading at modest valuations.

Teresa Heitsenrether to join the Board, bringing more than forty years of operating experience across data, analytics and technology at one of the world's largest financial institutions Larry Robbins to depart the Board after two years at CVS Health WOONSOCKET, R.I., Aug. 17, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the appointment of Teresa Heitsenrether to its Board of Directors and departure of Larry Robbins from its Board.

CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.